This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Brentjens RJ, Smith L, Reich L, Jakubowski AA . Development of spontaneous factor VIII inhibitor in association with acute graft-versus-host disease. Bone Marrow Transplant 2001; 27: 887–889.
Seidler CW, Mills LE, Flowers ME, Sullivan KM . Spontaneous factor VIII inhibitor occurring in association with chronic graft-versus-host disease. Am J Hematol 1994; 45: 240–243.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Wieliczka, M., Ganguly, S., Abhyankar, S. et al. Rituximab as a treatment for factor VIII inhibitor in a patient with chronic GVHD. Bone Marrow Transplant 49, 588 (2014). https://doi.org/10.1038/bmt.2013.229
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2013.229